Talis Biomedical Corporation (NASDAQ: TLIS)
$8.66
+0.2200 ( +2.61% ) 12.0K
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Market Data
Open
$8.66
Previous close
$8.44
Volume
12.0K
Market cap
$15.80M
Day range
$8.61 - $8.78
52 week range
$4.35 - $9.60
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 52 | Aug 10, 2023 |
| 8-k | 8K-related | 33 | Aug 10, 2023 |
| 3 | Insider transactions | 2 | Aug 02, 2023 |
| 4 | Insider transactions | 1 | Aug 02, 2023 |
| 8-k | 8K-related | 15 | Aug 02, 2023 |
| 8-k | 8K-related | 13 | Jul 27, 2023 |
| 8-k | 8K-related | 13 | Jul 24, 2023 |
| 4 | Insider transactions | 1 | Jul 18, 2023 |
| 8-k | 8K-related | 14 | Jul 05, 2023 |